InVitria sees strong demand for robust, animal component-free cell culture systems that not only meet regulatory guidelines, but also deliver consistency and performance.
Fort Collins, CO, USA, May 12, 2011 / B3C newswire / – InVitria announces its attendance at the 22nd Annual European Society for Animal Cell Technology (ESACT) Conference in Vienna, Austria, May 15-18. The ESACT conference is one of the largest cell culture conferences in the world, bringing together leading academia and industry scientists to advance cell-based technologies.
InVitria will be representing its line of animal component-free cell culture media products that improve productivity, increase safety, and reduce the costs of cell culture production. These products are effective in many cell lines, such as CHO, hybridoma, HEK293, VERO, MDCK, and stem cells.
“InVitria’s products address three main concerns facing cell culture systems today: improving productivity, enhancing consistency, and removing animal and undefined components from media,” said Shawn Smith, Vice President of Sales and Marketing for InVitria. “These concerns can now be overcome in a cost-effective manner by using products from InVitria.”
InVitria will be exhibiting in booth number 227 at ESACT. InVitria encourages attendees to stop by its booth to learn more about its products and how they can help cell culture scientists and process developers achieve their objectives.
InVitria develops, manufactures, and markets a portfolio of products used in cell culture, diagnostics, and bioproduction. InVitria’s products address customer needs for defined, animal component-free cell culture supplements in stem cell technology, regenerative medicine, biomanufacturing, diagnostics, biopharmaceutical formulation, cell-based vaccines, and general life science research.